Rankings
▼
Calendar
ELAN Q4 2021 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
Q4 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1.1B
-2.3% YoY
Gross Profit
$462M
41.5% margin
Operating Income
$43M
3.9% margin
Net Income
-$104M
-9.3% margin
EPS (Diluted)
$-0.20
QoQ Revenue Growth
-1.6%
Cash Flow
Operating Cash Flow
$223M
Free Cash Flow
$132M
Stock-Based Comp.
$18M
Balance Sheet
Total Assets
$16.5B
Total Liabilities
$9.0B
Stockholders' Equity
$7.5B
Cash & Equivalents
$638M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.1B
$1.1B
-2.3%
Gross Profit
$462M
$380M
+21.6%
Operating Income
$43M
-$107M
+140.2%
Net Income
-$104M
-$323M
+67.8%
Revenue Segments
Farm Animal
$604M
54%
Pet Health
$494M
44%
Contract Manufacturing
$15M
1%
Geographic Segments
Non-US
$610M
55%
UNITED STATES
$503M
45%
← FY 2021
All Quarters
Q1 2022 →